For information about CUVPOSA™ please consult the product monograph
CUVPOSA™ (Glycopyrrolate) is indicated to reduce chronic severe drooling in patients aged 3 –18 years with neurologic conditions associated with problem drooling (e.g., cerebral palsy).
To consult the product monograph, click here
The contents of this site are for informational purposes only and are not intended, nor should they be used, as a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician, pharmacist or other qualified health care provider with any questions you may have regarding a medical condition and/or the use of these products. Also read the product monograph and the consumer information included in the product packaging.